Mt-Hsp70 Homolog, Ssc2p, Required for Maturation of Yeast Frataxin and Mitochondrial Iron Homeostasis*

Simon A. B. KnightDagger , Naresh Babu V. Sepuri§, Debkumar Pain§, and Andrew DancisDagger

From the Dagger  Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6100 and the § Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Here we show that the yeast mitochondrial chaperone Ssc2p, a homolog of mt-Hsp70, plays a critical role in mitochondrial iron homeostasis. Yeast with ssc2-1 mutations were identified by a screen for altered iron-dependent gene regulation and mitochondrial dysfunction. These mutants exhibit increased cellular iron uptake, and the iron accumulates exclusively within mitochondria. Yfh1p is homologous to frataxin, the human protein implicated in the neurodegenerative disease, Friedreich's ataxia. Like mutants of yfh1, ssc2-1 mutants accumulate vast quantities of iron in mitochondria. Furthermore, using import studies with isolated mitochondria, we demonstrate a specific role for Ssc2p in the maturation of Yfh1p within this organelle. This function for a mitochondrial Hsp70 chaperone is likely to be conserved, implying that a human homolog of Ssc2p may be involved in iron homeostasis and in neurodegenerative disease.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Iron is required as a cofactor for critical proteins within mitochondria of eukaryotic cells. These proteins include heme and iron-sulfur proteins involved in diverse processes such as cellular respiration and the synthesis of metabolic intermediates. However iron is also extremely toxic, capable of generating damaging free radicals (3). Therefore, homeostatic mechanisms exist that regulate iron levels and iron protein levels within mitochondria. Yfh1p is a mitochondrial protein of Saccharomyces cerevisiae that is involved in this homeostasis (4-8). Yeast with mutations in yfh1 accumulate iron within mitochondria (4, 5) and yet are deficient in some mitochondrial iron proteins (5, 6). Yfh1p is homologous to the human protein frataxin (7, 8), and mutations in frataxin are associated with the neurodegenerative disease Friedreich's ataxia (9). At the cellular level, iron accumulation occurs in affected tissues in these patients, and iron proteins such as aconitase and cytochrome oxidase are deficient (6).

The manner in which Yfh1p in the yeast (or frataxin in humans) affects iron homeostasis of mitochondria has not been defined. This work implicates a member of the class of Hsp70 proteins in this process. Two distinct Hsp70 proteins are found in mitochondria of S. cerevisiae (1). One of these, Ssc1p, is essential for viability and is involved in the import and subsequent folding of nuclear-encoded proteins in mitochondria (10-13). The second, Ssc2p,1 is one thousand-fold less abundant, and its physiological role has not been previously determined (1). We show here that Ssc2p plays a role in mitochondrial iron usage and in the maturation of Yfh1p.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Yeast Strains and Growth Media-- Methods for yeast manipulations and growth media have been described (14). In YE the carbon source was replaced with 3% ethanol. For some experiments with rho- strains, the carbon source was 2% raffinose. The yeast strains used were: CM3260, CM3262, 61, and 81 (15). Strains 81 or 61 were exposed to ethidium bromide, creating strains 81rho0 and 61rho0 respectively. Strain 35-5B (MATalpha trp1-63 leu2-3, 112 gcn4-101 his3-609 FRE1-HIS3::URA3 ssc2-1) carried the ssc2-1 allele. The following strains were derived from backcrosses of this mutant: 191-33C (MATa ssc2-1); a complete tetrad 191-36A(ssc2-1), 191-36B(ssc2-1), 191-36C(SSC2), 191-36D(SSC2); Ura- derivatives 341-5B and 341-2A (MATalpha ura3-52 ssc2-1); 341-4A and 341-8A (MATa ura3-52 ssc2-1). The yfh1 deletion strain, Delta yfh1, was generously provided by Dr. Jerry Kaplan (4) and was backcrossed to strain 61, creating 5DDelta yfh1 (MATa Delta yfh1::HIS3).

Assays-- The assay for ferric reductase was a filter lift assay (16), modified by the addition of 50 µM copper sulfate and 10 µM ferric ammonium sulfate to YPD agar plates for growth of the colonies to be assayed. Measurement of high affinity radioactive iron uptake rate has been described (15). To assess mitochondrial iron, the cells were grown for 16 h (6-8 doublings) in SD raffinose with different concentrations of radioactive 55Fe, and mitochondria were purified (17). The cells for the microscopy were grown in SD raffinose with 5 µM ferric ammonium sulfate as above. The preparation of yeast for electron microscopy has been described (18). The electron microscope was a Jeol 100CX model and was fitted with an Energy Dispersive Spectrophotometer (19). Mitochondrial import studies were described previously (20). Briefly, import reactions containing 100 µg of mitochondria were initiated by adding urea-denatured preprotein (30-40 ng). Import reaction mixtures contained 4 mM ATP and 1 mM GTP. Following import at 20 °C for 5 or 15 min, reaction mixtures were treated with trypsin (0.1 mg/ml) for 30 min at 0 °C. The protease was inactivated, and the samples were analyzed by SDS-polyacrylamide gel electrophoresis and fluorography.

Plasmids and DNA Manipulations-- Plasmid pSC30, isolated from a yeast genomic library (21), contained yeast genomic sequences from Chromosome XII, coordinates 858900-870300, and included open reading frames SUR4, ROM2, ARC18, and SSC2 (YLR369W). Plasmid pSC30-3, containing SSC2, was created by subcloning the EcoRI-KpnI genomic fragment. The plasmid pSC30-3Delta not contained a frameshift mutation in the open reading frame at the unique NotI site. For meiotic mapping, the EcoRI fragment from within ROM2 inserted into YIp5 (prom2-YIp5) was integrated into CM3260 at its unique SacI site, and this strain was crossed with 35-5B (ssc2-1). The YFH1 open reading frame was inserted into the NdeI-XhoI sites of vector pET21b (Novagen), or into the NdeI-KpnI sites of vector pET21b/CCHL-Protein A,2 creating plasmids 446 and 436, respectively.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The present investigation was an outgrowth of our general interest in iron trafficking in S. cerevisiae. Yeast cells were subjected to a selection procedure designed to detect mutants with abnormal iron metabolism. The iron-repressible promoter of the FRE1 gene was fused to the HIS3 coding region and integrated into the genome of a haploid yeast strain. Cells harboring this gene fusion were then cultured in a medium supplemented with iron but without histidine. Mutants were selected that were unable to repress FRE1-driven gene transcription, indicating a defect in iron uptake (15), iron sensing (22), or iron distribution. A subset of these mutants was identified that was unable to grow on medium containing ethanol as a carbon source, an indicator of mitochondrial dysfunction.

One such mutant, 35-5B, was chosen for further study. The mutant retained ferric reductase activity under conditions (available iron and copper) that led to repressed activity in the wild-type. This assay, used to track the mutation in genetic analyses, indicated that the mutant phenotype was recessive. Sporulation of this diploid strain which yielded 30 tetrads showing 2+:2- segregation of the mutant phenotype indicated that the mutation was at a single locus. The mutant was then transformed with a genomic library, and a complementing plasmid pSC30 was isolated (21). The complementing activity was retained by pSC30-3 which contained the single complete open reading frame from SSC2, and this activity was abrogated by the frameshift mutation introduced into pSC30-3Delta not. Rescue of the ssc2-1 allele and sequence analysis identified a single T to G point mutation at nucleotide 658 within the open reading frame, thereby generating a stop codon within the amino-terminal portion of the predicted protein. The correctness of the identification of SSC2 as the wild-type allele of the mutation in the 35-5B strain was further verified by meiotic mapping. A URA3 marked allele of the genomic fragment carried on pSC30 was integrated into the parental strain and crossed with the ura3-52 mutant strain 35-5B. Recombination between the mutant phenotype and the URA3 marker was not observed in 12 tetrads analyzed.

To evaluate mitochondrial function in the ssc2-1 strain, we investigated the growth of this strain on media with nonfermentable carbon sources. Heterogeneity arose because of loss or inactivation of mtDNA in some cells from the mutant population, as has previously been described for ssc2 mutants (1). The degree of mtDNA damage in the mutant population was ascertained by crossing haploid ssc2-1 mutant cells with rho0 tester cells of the opposite mating type. Diploid clones derived from these zygotes were evaluated for the ability to grow on ethanol-based medium, and 8 of 18 (44%) did not grow (Fig. 1A), indicating inactivation of mtDNA in those cells. Slow growth of ssc2 mutants was reflected in the small colony size (Fig. 1B), as has been described previously (1). The slow growth was exacerbated at lower (23 °C) or higher (37 °C) incubation temperatures, suggesting susceptibility of the mutants to environmental stresses (Fig. 1B).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Phenotypes of the ssc2-1 mutants. A, mtDNA inactivation in strain 341-5B (ssc2-1). Strains 81rho0 (1. rho0) and 341-5B (2. ssc2-1) were crossed and zygotes were manipulated. Other haploid controls were 191-33C (3. ssc2-1), 61 (4. WT), 61rho0 (5. rho0). Haploids and diploid clones arising from the cross were transferred to YE (Ethanol) or YPD (Glucose). Failure of the diploid clones to grow on ethanol plates is diagnostic of mtDNA inactivation in the parental strain, 341-5B (ssc2-1). B, growth characteristics of the mutants: temperature and iron sensitivity. Diploid x191-36 was sporulated, and spore clones carrying the mutant allele ssc2-1 (A, B) or the wild-type allele SSC2 (C, D) were examined for growth on YPD agar at different temperatures (30 °C, 23 °C, 37 °C) or for growth on SD medium containing 1 mM ferrozine (Chelator, no added iron; Iron, 250 µM ferric ammonium added). The relative concentrations of the inocula spotted onto the plates are indicated by 1 (103 cells/10 µl) and 1:10. The wild-type clone C appeared pigmented because of a genetic trait unlinked to SSC2. C, high affinity cellular iron uptake increased in the ssc1-2 mutants. The spore clones were grown to logarithmic phase in YPD, and iron uptake was assayed using 1 µM 55Fe radionuclide in 50 mM sodium citrate buffer, pH 6.5, as described. Data are the mean ± S.D. of triplicate measurements. D, mitochondrial iron content increased in the ssc1-2 mutants. Strains 61 (WT), 61rho0 (rho0), and 191-33C (ssc2-1) were grown in media with 0.9, 1.8, or 5 µM iron, and the mitochondrial iron content was assayed as described.

A link to iron metabolism was anticipated because of the way the mutants were selected. When the ssc2-1 mutant tetrad clones, 191-36A and 191-36B, were spotted on plates containing the iron chelator ferrozine, normal growth was observed (Fig. 1B). Conversely, growth of these mutants was inhibited in the presence of iron (Fig. 1B), suggesting a toxic effect of the iron on cell proliferation or cell viability. This iron-sensitive growth was correlated with a marked increase in the rate of high affinity iron uptake in the mutants (Fig. 1C). These observations show that the normal homeostatic regulation of cellular iron uptake was perturbed in the ssc2-1 mutant.

To directly assess the iron content of the mitochondria, cells from the wild-type, a congenic rho0 strain, and the ssc2-1 mutant were cultured in media containing different concentrations of iron-55 radionuclide. Mitochondria were purified (17), and the total radioactive iron content was evaluated. In the wild-type, mitochondrial iron content varied little with the different iron concentrations of the growth medium (Fig. 1D, wild-type values 1.8 to 2.6 pmol/µg of protein). By contrast, the ssc2-1 mutant strain accumulated iron within mitochondria in proportion to the iron content of the growth medium. When grown in 0.9, 1.8, or 5 µM 55Fe-containing medium, the mutant accumulated 9.5, 29.4, or 107.2 pmol/µg of mitochondrial protein, respectively (Fig. 1D). The rho0 strain did not exhibit comparable mitochondrial iron accumulation, and so the effect could not be ascribed to the absence of mtDNA. We wondered if the increased mitochondrial iron content in the mutant represented a primary problem or a consequence of the increased cellular iron uptake "spilling over" into the mitochondria. When the iron content of cellular fractions was analyzed, iron accumulation in the mutant was observed exclusively within the mitochondrial fraction. The post-mitochondrial supernatant, in fact, appeared moderately depleted of iron in the mutant compared with the wild-type strain (5.5 compared with 9.2 pmol/µg of protein). These results suggest that the increase in mitochondrial iron in the mutant was not a secondary effect resulting from increased cytosolic iron but rather a primary defect.

The accumulation of iron in the ssc2-1 mutant mitochondria was so great that it was visible by electron microscopy. The mitochondria were packed with electron-dense material in over 50% of the cells (Fig. 2A). The fact that the deposits indeed contained iron was confirmed by Energy Dispersive X-ray Spectroscopy. The wild-type yeast strain contained no such iron deposits, and a congenic rho0 strain showed only rare deposits in less than 5% of cells, indicating that this appearance was specific for the ssc2-1 mutant. Under higher magnifications, the mitochondrial double membrane could be seen (arrow m, Fig. 2B), and the iron deposits were evident within the mitochondrial matrix. The deposits were granular and discontinuous in appearance, as if separated by intramitochondrial cristae (Fig. 2, B and D). In some cells, the deposit-laden mitochondria were arrayed around the nucleus (Fig. 2D). We conclude that a loss of homeostatic control in the ssc2-1 mutant leads to accumulation of vast quantities of iron as electron-dense bodies within the mitochondria.


View larger version (186K):
[in this window]
[in a new window]
 
Fig. 2.   Electron microscopy showing iron-laden mitochondria. A, ssc2-1 cells from strain 191-33C with accumulated iron visible as dense bodies. B, higher magnification (× 11,000) view of a single ssc2-1 cell showing accumulated iron within mitochondria. Mitochondria (m) and nucleus (n) are indicated. C, wild-type cell from strain 61. D, single ssc2-1 cell with iron-laden mitochondria ringing the nucleus. The calibration bar in each panel represents 1 µm.

Some of the features described here for the ssc2-1 mutant have been reported for yeast with mutation in yfh1. Therefore, we compared the two mutant strains directly. Both were slow growing and exhibited frequent destabilization or inactivation of the mitochondrial genome (4, 7). Both retained ferric reductase activity under conditions that repress activity in the wild-type. Both exhibited elevated levels of high affinity iron uptake (354 pmol/106 cells/h for the ssc2-1 mutant and 464 for the yfh1 mutant, compared with 17 for the wild-type). Most striking was that both mutants exhibited increased mitochondrial iron content (107 pmol of iron/µg of protein for the ssc2-1 mutant and 47 for the yfh1 mutant, compared with 2.6 for the wild-type). The increased iron within mitochondria in both strains occurred without an increase in cytosolic iron (2.2 pmol of iron/µg of protein for the ssc2-1 mutant and 1.2 for the yfh1 mutant compared with 3.0 for the wild-type). Thus, the ssc2-1 and yfh1 mutants strongly resemble each other with respect to their mutant phenotypes.

The similar phenotypes of ssc2-1 and yfh1 mutants suggested that the corresponding proteins might function together. We therefore considered that Ssc2p might function specifically in the import or folding of Yfh1p, analogous to the known effects of Ssc1p on import and folding of other mitochondrial preproteins. To test this hypothesis, mitochondria were isolated from the wild-type (WT) and ssc2-1 mutant (M) strains, and the import of Yfh1 preprotein was allowed to proceed, after which the unimported precursor was removed by digestion with trypsin. Two new fragments (i and m) acquired trypsin resistance, suggesting that the import of Yfh1 preprotein was followed by two processing cleavages (Fig. 3A). The Yfh1 preprotein (p) migrated at a molecular mass ~29 kDa, although the predicted size was only 19.5 kDa, perhaps because of the acidic nature of the protein. The initial processing cleavage removed ~2 kDa from the amino terminus of the preprotein and generated an intermediate size polypeptide (i) migrating at ~27 kDa. A subsequent cleavage removed ~4 kDa from the amino terminus of the intermediate form, generating a mature product (m) of ~23 kDa that was also trypsin-resistant (Fig. 3A). In the ssc2-1 mutant, by contrast, import of Yfh1 preprotein was efficient as judged by the appearance of the protease-resistant intermediate polypeptide (i), but the conversion to the mature form was impaired. After 5 min of incubation, the level of the mature form was decreased compared with the wild-type (Fig. 3A, m in lanes 2, 3, 4, and 5), whereas the level of the intermediate form of Yfh1 was increased compared with the wild-type (Fig. 3A, i in lanes 2, 3, 4, and 5).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Yfh1 preprotein processing impaired in ssc2-1 mitochondria. Import of urea-denatured precursors of Yfh1 (A), Yfh1-Protein A (B), or Put2 (C) were evaluated in mitochondria purified from wild-type (WT) or ssc2-1 (M) strains. Import reactions were allowed to proceed for 5 min (5') or 15 min (15') at 20 °C. Where indicated, unimported precursor was digested by trypsin. p, i, and m signify the precursor, the intermediate, and the mature form, respectively. Lane 1 in each panel (Std) indicates 35% of the precursor used per import assay.

Import studies of the preYfh1-Protein A fusion similarly generated two protease-resistant polypeptide forms, differing from the precursor by ~2 and ~6 kDa (Fig. 3B). This experiment also demonstrated that the proteolytic processing steps must be occurring at the amino terminus of the Yfh1 preprotein, because Yfh1 and Yfh1-Protein A precursors were processed identically. The level of the mature Yfh1-Protein A fusion protein (m) was again decreased in the ssc2-1 strain (M) compared with the wild-type (WT) (Fig. 3B, m in lanes 2, 3, 4, and 5). A reciprocal increase in the intermediate form was noted in the early (5 min) time point in the mutant, consistent with an inefficient second processing step (Fig. 3B, i in lanes 2, 3, 4, and 5). We also studied the import of prePut2 (20), the precursor of a mitochondrial matrix protein involved in proline biosynthesis, and in this case, no difference in the appearance of protease-protected forms was observed in the ssc2-1 mutant compared with the wild-type (Fig. 3C). Consistent with our prePut2 control, earlier studies failed to demonstrate alterations in the import or processing of several other preproteins by mitochondria isolated from ssc2 mutant strains (1). These data suggest that the defect in preprotein processing that exists in the ssc2-1 strain is specific for the Yfh1 preprotein.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We present the following model to explain these findings (Fig. 4). i) The primary defect in the ssc2-1 mutant leads to impaired maturation of Yfh1p (yellow in Fig. 4). ii) In the ssc2-1 mutant, iron uptake into the mitochondria is greatly increased, reducing cytoplasmic iron concentrations. The iron sensor-regulator, Aft1p, which ordinarily does not affect mitochondrial iron levels, responds to the decreased cytoplasmic iron by activation of the cellular iron uptake system (blue in Fig. 4) (22). Thus, iron is continually fed from the medium to the cytoplasm to the mitochondria (red in Fig. 4). The iron accumulates as dense bodies in the mitochondria that are visible by electron microscopy. iii) Despite the excess iron, the activities of a number of mitochondrial iron proteins are decreased (e.g. in yfh1 mutants, respiratory chain complexes I, II, III, IV, and the iron-sulfur protein, aconitase (5, 6)). In this model, Ssc2p is required for the generation of mature Yfh1p, thereby regulating iron usage and assembly of iron proteins within the mitochondria. A direct role for Ssc2p in these processes is also possible.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Model for the involvement of Ssc2p in Yfh1 preprotein processing and iron homeostasis. Ovals represent yeast cells, the wild-type on the left and the mutant (ssc2-1) on the right. The box enclosed by the double line represents the mitochondria. Yellow indicates protein trafficking and processing pathways (Yfh1p translocation and maturation). Red indicates iron trafficking pathways, with boxes showing steady state iron pools. Blue indicates regulatory loops, with Aft1p controlling uptake at the plasma membrane and Yfh1p/Ssc2p controlling iron accumulation within the mitochondria.

We have shown that Ssc2p participates in the second processing cleavage of Yfh1 following an initial cleavage of the extreme amino-terminal signal sequence. To do this, Ssc2p might itself be acting as the processing protease. The association of proteolytic and chaperone activities in a single complex has been described for mitochondrial proteins such as Lon (23) and Afg3p and Rca1p (24). Alternatively, Ssc2p could mediate maturation of Yfh1 preprotein indirectly via effects on folding or complex formation. The iron-sulfur protein of the cytochrome bc1 complex provides an example of an association between preprotein assembly and two-step proteolytic processing. The iron-sulfur preprotein is imported into the matrix, and the signal sequence is cleaved by the matrix processing peptidase. A second processing cleavage by the mitochondrial intermediate peptidase then occurs upon assembly of the mature protein into complex II of the mitochondrial inner membrane (25). In analogous fashion, Ssc2p might mediate processing and insertion of Yfh1p into a complex. However, physical interaction between Yfh1p and Ssc2p has not yet been demonstrated, and assembly partners for Yfh1p are not known.

Ssc2p function is necessary for normal iron homeostasis, and defects of Ssc2p are correlated with iron accumulation within the mitochondria. This may result from increased activity of mitochondrial iron importers or decreased activity of exporters. Another possibility is that diversion of iron into an inactive or inaccessible form induces increased iron import into mitochondria, causing the massive accumulations that we have observed. The iron, like intermediates in some storage diseases (26), may accumulate in a metabolic dead end, causing deficiencies of iron proteins and iron-protein complexes (5, 6). Ssc2p, through its effects on the maturation and assembly of Yfh1 and other proteins, might regulate this iron accumulation process.

Yfh1p is homologous to the human protein frataxin, which is defective in most cases of the neurodegenerative disease Friedreich's ataxia (4-9). Specialized Hsp70 proteins within different cellular compartments are also conserved between yeast and humans (e.g. BiP in the endoplasmic reticulum and mt-Hsp70 in the mitochondria (10)). Therefore, in humans, a specialized mitochondrial form of Hsp70, analogous to Ssc2p, is likely to be involved in the maturation of human frataxin. Our inability to identify such a homolog in the human sequence data bases at this time may relate to the incomplete nature of these data bases and the low abundance of the transcript. The human homolog of Ssc2p might be defective in forms of Friedreich's ataxia that are not explained by frataxin mutations (27) or in other neurodegenerative diseases with a mitochondrial basis.

    ACKNOWLEDGEMENTS

We thank Mikhail Kogan for technical assistance and Robert Smith and Neelima Shah of the EM Core Facility of the Department of Pathology and Laboratory Medicine of The University of Pennsylvania for assistance with the electron microscopy. We thank Jerry Kaplan for the pTF63 plasmid containing YFH1 and the Delta yfh1 strain (6). We are grateful to Joseph Dancis, Michael Marks, and Donna Gordon for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by grants from the W. W. Smith Charitable Trust (to A. D. and D. P.), from the Lucille P. Markey Charitable Trust (to A. D.), and from the American Heart Association (to D. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Medicine, Division of Hematology-Oncology, University of Pennsylvania, 1009 Stellar-Chance Laboratories, 422 Curie Blvd., Philadelphia, PA 19104-6100. Tel.: 215-573-6275; Fax: 215-662-7617; E-mail: adancis{at}mail.med.upenn.edu.

1 Note on nomenclature: the gene, SSC2, corresponding to the open reading frame YLR369W was recently renamed SSQ1 while this paper was in press. The gene can be found in the S. cerevisiae Genome Database under the name SSQ1. The name SSH1 was used in a previous publication (1), but that name also designates YBR283C (2).

2 D. Pain, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Schilke, B., Forster, J., Davis, J., James, P., Walter, W., Laloraya, S., Johnson, J., Miao, B., and Craig, E. (1996) J. Cell Biol. 134, 603-613[Abstract]
  2. Finke, K., Plath, K., Panzner, S., Prehn, S., Rapoport, T. A., Hartmann, E., and Sommer, T. (1996) EMBO J. 15, 1482-1494[Abstract]
  3. Cammack, R., Wrigglesworth, J. M., and Baum, H. (1990) in Iron Transport and Storage (Ponka, P., Schulman, H. M., and Woodworth, R. C., eds), pp. 17-39, CRC Press, Cleveland, OH
  4. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., and Kaplan, J. (1997) Science 276, 1709-1712[Abstract/Free Full Text]
  5. Foury, F., and Cazzalini, O. (1997) FEBS Lett. 411, 373-377[CrossRef][Medline] [Order article via Infotrieve]
  6. Rotig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., and Rustin, P. (1997) Nat. Genet. 17, 215-217[Medline] [Order article via Infotrieve]
  7. Wilson, R. B., and Roof, D. M. (1997) Nat. Genet. 16, 352-357[Medline] [Order article via Infotrieve]
  8. Koutnikova, H., Campuzano, V., Foury, F., Dolle, P., Cazzalini, O., and Koenig, M. (1997) Nat. Genet. 16, 345-351[Medline] [Order article via Infotrieve]
  9. Campuzano, V., Montermini, L., Molto, M. D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al.. (1996) Science 271, 1423-1427[Abstract]
  10. Morimoto, R. I., Tissieres, A., and Georgopoulos, C. (eds) (1994) The Biology of Heat Shock Proteins and Molecular Chaperones, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  11. Kang, P. J., Ostermann, J., Shilling, J., Neupert, W., Craig, E. A., and Pfanner, N. (1990) Nature 348, 137-143[CrossRef][Medline] [Order article via Infotrieve]
  12. Gambill, B. D., Voos, W., Kang, P. J., Miao, B., Langer, T., Craig, E. A., and Pfanner, N. (1993) J. Cell Biol. 123, 109-117[Abstract]
  13. Horst, M., Oppliger, W., Rospert, S., Schonfeld, H. J., Schatz, G., and Azem, A. (1997) EMBO J. 16, 1842-1849[Abstract/Free Full Text]
  14. Sherman, F. (1991) in Guide to Yeast Genetics and Molecular Biology (Guthrie, C., and Fink, G. R., eds), pp. 3-21, Academic Press, New York
  15. Dancis, A., Yuan, D. S., Haile, D., Askwith, C., Elde, D., Moehle, C., Kaplan, J., and Klausner, R. D. (1994) Cell 76, 393-402[Medline] [Order article via Infotrieve]
  16. Dancis, A., Klausner, R. D., Hinnebusch, A. G., and Barriocanal, J. G. (1990) Mol. Cell. Biol. 10, 2294-2301[Medline] [Order article via Infotrieve]
  17. Murakami, H., Pain, D., and Blobel, G. (1988) J. Cell Biol. 107, 2051-2057[Abstract]
  18. Byers, B., and Goetsch, L. (1991) in Guide to Yeast Genetics and Molecular Biology (Guthrie, C., and Fink, G. R., eds), pp. 602-608, Academic Press, New York
  19. Goldstein, J. I., Newbury, P., Echlin, P., Joy, D. C., Fiori, C., and Lifshin, E. (1981) Scanning Electron Microscopy and X-Ray Microanalysis, Plenum, New York
  20. Sepuri, N. B. V., Schulke, N., and Pain, D. (1998) J. Biol. Chem. 273, 1420-1424[Abstract/Free Full Text]
  21. Rose, M. D., Novick, P., Thomas, J. H., Botstein, D., and Fink, G. R. (1987) Gene 60, 237-243[CrossRef][Medline] [Order article via Infotrieve]
  22. Yamaguchi-Iwai, Y., Dancis, A., and Klausner, R. D. (1995) EMBO J. 14, 1231-1239[Abstract]
  23. Rep, M., van Dijl, J. M., Suda, K., Schatz, G., Grivell, L. A., and Suzuki, C. K. (1996) Science 274, 103-106[Abstract/Free Full Text]
  24. Langer, T., and Neupert, W. (1996) Experientia 52, 1069-1076[Medline] [Order article via Infotrieve]
  25. Graham, L. A., Brandt, U., Sargent, J. S., and Trumpower, B. L. (1993) J. Bioenerg. Biomembr. 25, 245-257[Medline] [Order article via Infotrieve]
  26. Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds) (1995) The Metabolic and Molecular Basis of Inherited Diseases, pp. 2427-2579, McGraw-Hill, New York
  27. Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds) (1995) The Metabolic and Molecular Basis of Inherited Diseases, pp. 1860-1866, McGraw-Hill, New York


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.